Grandes dosis de corticoides sistémicos en pacientes con síndrome de Stevens-Johnson y necrólisis epidérmica tóxica: descripción de siete casos y revisión de la literatura

Diaz, Juan Carlos; Bonilla, Diego; Ramírez, Ana Francisca; Herrera, Melba Cristina; Ramírez, Luis Fernando; Serrano, Carlos Daniel.
Rev. Asoc. Colomb. Dermatol. Cir. Dermatol ; 19(1)mar. 2011. tab, ilus
Artículo en Español | LILACS | ID: lil-651959

Documentos relacionados

  1. Stevens-Johnson syndrome in children.
  2. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis.
  3. Stevens-Johnson syndrome and toxic epidermal necrolysis from pathologist's point of view.
  4. Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.
  5. Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.
  6. APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts.
  7. Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.
  8. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).
  9. Enfortumab Vedotin-Associated Toxic Epidermal Necrolysis-like Toxic Erythema of Chemotherapy.
  10. Infantile toxic epidermal necrolysis: Successful treatment of an 8-week-old with intravenous immunoglobulin and amniotic membrane transplant.